Check out our most popular compounded medications! Get Started
Morphine Sulfate 200 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to treat various types of pain including chronic, cancer, postoperative, neuropathic, and arthritis pain. The slow release mechanism reduces dosing frequency and improves patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Morphine Sulfate 200 mg Slow Release Capsules are a potent, long-acting opioid analgesic designed to manage moderate to severe pain. This formulation is specifically engineered to provide a steady, consistent release of the active ingredient, Morphine Sulfate, over an extended period of time.
The slow release formulation of Morphine Sulfate 200 mg Capsules is achieved through the use of Methocel E4M, a type of controlled-release polymer. This polymer is designed to gradually release the encapsulated medication over time, offering sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
However, this formulation is not recommended for patients dealing with acute pain, as it may not provide immediate or adequate pain relief. It is also important for patients to be aware of potential side effects, which may include drowsiness, dizziness, and confusion. As such, patients are advised not to drive or operate machinery while taking this medication.
Furthermore, Morphine Sulfate 200 mg Slow Release Capsules may be habit-forming and should only be taken as prescribed by a healthcare professional. Overuse or misuse can lead to dependency and other serious health issues. Therefore, it is crucial for prescribers to be aware of these risks and prescribe this medication for the shortest duration necessary.
Additionally, Morphine Sulfate 200 mg Slow Release Capsules may cause respiratory depression and should be used with caution in patients with respiratory conditions. Prescribers should closely monitor these patients and adjust the dosage as necessary.
If you have any questions or concerns about Morphine Sulfate 200 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. We are here to provide you with the information and support you need to ensure safe and appropriate use of this medication.
Morphine Sulfate 200 mg Slow Release Capsules are a potent analgesic medication indicated for the management of moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the active ingredient over an extended period. This sustained release profile offers prolonged therapeutic effects, reduces the need for frequent dosing, and aids in improving patient compliance, particularly for medications requiring a controlled and extended release.
It is crucial to note that Morphine Sulfate 200 mg Slow Release Capsules should not be administered to patients with known hypersensitivity to morphine or other opioids. Additionally, patients with significant respiratory depression, acute or severe bronchial asthma, or other severe respiratory conditions should avoid this medication. Caution is advised for patients with renal or hepatic impairment, as well as those with a history of substance abuse or mental illness.
Morphine Sulfate 200 mg Slow Release Capsules may interact with a variety of other medications, including but not limited to other opioids, sedatives, hypnotics, anxiolytics, muscle relaxants, antihistamines, and anticholinergics. Concomitant use of these medications may increase the risk of respiratory depression, hypotension, profound sedation, coma, and even death. Interactions may also occur with monoamine oxidase inhibitors (MAOIs) and other drugs that affect serotonin levels, such as selective serotonin reuptake inhibitors (SSRIs).
Furthermore, Morphine Sulfate 200 mg Slow Release Capsules may interact with alcohol. Concurrent use may heighten the risk of respiratory depression, hypotension, profound sedation, coma, and death. It is essential to consult with a healthcare provider to understand the potential interactions and risks associated with this medication.
Morphine Sulfate 200 mg Slow Release Capsules are a potent, extended-release opioid medication designed to manage moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative formulation allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects and a steady level of pain relief.
The slow-release mechanism of these capsules reduces the dosing frequency, typically to once a day, and improves patient compliance, particularly for those requiring a controlled and prolonged release profile. The capsules are taken orally and should be consumed with food for optimal absorption. It is crucial to adhere to the prescribed dosage and frequency set by your healthcare provider to ensure safety and efficacy.
Morphine Sulfate 200 mg Slow Release Capsules are versatile in their application, providing relief for various disease states. The medication functions by binding to opioid receptors in the brain and spinal cord, effectively reducing the perception of pain and providing relief.
It is essential to communicate with your healthcare provider about any side effects you may experience. Furthermore, it is important to be aware of the potential for addiction and abuse associated with this medication due to its opioid nature.
If you have any questions or concerns about Morphine Sulfate 200 mg Slow Release Capsules, do not hesitate to reach out to your healthcare provider or pharmacist. They can provide further information on how this medication works and how it can assist in managing your pain effectively and safely.
Morphine Sulfate 200 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time, providing sustained therapeutic effects.
The controlled-release polymer, Methocel E4M, is used to ensure that the medication is released gradually over a prolonged period. This helps to maintain a steady level of the medication in the body, reducing the need for frequent dosing and improving patient compliance.
The slow release of the medication provides sustained therapeutic effects, which means the patient experiences consistent relief from their symptoms. It also reduces the frequency of dosing, making it more convenient for the patient and improving their adherence to the medication regimen.
'Improved patient compliance' refers to the increased likelihood of a patient correctly following their prescribed medication regimen. This is often improved with medications that require less frequent dosing, such as Morphine Sulfate 200 mg Slow Release Capsules.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It ensures the gradual and prolonged release of the active ingredient, Morphine Sulfate, into the body.
The dosing frequency of Morphine Sulfate 200 mg Slow Release Capsules will depend on the specific needs and response of the individual patient. This should be determined by a healthcare professional.
Morphine Sulfate is a powerful pain reliever. The slow release of this medication provides sustained relief from severe pain over an extended period of time.
No, Morphine Sulfate 200 mg Slow Release Capsules are a strong medication and should only be taken under the supervision of a healthcare professional. They are typically prescribed for patients who require continuous, long-term pain relief.
As with any medication, Morphine Sulfate 200 mg Slow Release Capsules can have side effects. These can include drowsiness, constipation, and nausea. Any concerns about side effects should be discussed with a healthcare professional.
Whether Morphine Sulfate 200 mg Slow Release Capsules can be taken with other medications will depend on the specific medications in question. It is important to discuss all current medications with a healthcare professional before starting any new medication, including Morphine Sulfate 200 mg Slow Release Capsules.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
